Researchers observed “no symptoms of impairment” and “no significant impact on driving ability” in study subjects who inhaled CBD-dominant cigarettes.
Topic: CBD
Researchers identified “an antipsychotic medication sparing effect of CBD-cigarettes as adjunctive therapy in acutely psychotic patients.”
Analyses by the FDA and others have consistently reported that unregulated CBD products are of variable purity and may contain adulterants.
Authors concluded, “Daily administration of CBD to patients with a recent diagnosis of COVID-19 did not alter the clinical evolution in the first 28 days of follow-up.”
Among those patients who reported using CBD, 81 percent said that the use of CBD products “improved their pain.”
Investigators concluded, “The potential for cannabinoids to be used as an alternative to augment or replace conventional primary cancer treatments definitely justifies further research.”
Eighty-three percent of those surveyed that they would recommend the use of CBD products to other parents caring for autistic children.
Following their initiation of CBD-dominant cannabis, subjects experienced a significant decrease in anxiety and depressive symptoms; non-users did not experience a similar reduction.